Sign in / Join Now
ETFs & Funds
Jim Van Meerten
- 100% Barchart technical buy signal - 5 new highs and up 27.51% in the last month - Relative Strength Index 72.31%
Add a reply...
Latest StockTalks »
people get RPRX breaking news and analysis by email alert.
Get email alerts on RPRX »
Repros Therapeutics Inc.
Get latest price
From other sites
Repros Requests Meeting With FDA To Discuss Phase 3 Requirements For Proellex® In The Treatment Of Endometriosis
at TheStreet (Dec 19, 2016)
Repros Requests Meeting With FDA To Discuss Phase 3 Requirements For Proellex® In The Treatment Of Symptomatic Uterine Fibroids
at TheStreet (Dec 12, 2016)
FDA Advisory Committee Discusses Clinical Trial Designs For Obesity-Related Hypogonadism
at TheStreet (Dec 6, 2016)
Repros Therapeutics Shares Rally Following Ladenburg Upgrade To Buy, Positive Data
at Benzinga (Nov 16, 2016)
Repros Therapeutics Higher Off Positive Data For Proellex
at Benzinga (Nov 15, 2016)